Logo image of RAGE.CA

RENEGADE GOLD INC (RAGE.CA) Stock Fundamental Analysis

Canada - TSX-V:RAGE - CA75974M1059 - Common Stock

0.11 CAD
0 (0%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

1

Overall RAGE gets a fundamental rating of 1 out of 10. We evaluated RAGE against 807 industry peers in the Metals & Mining industry. RAGE has a bad profitability rating. Also its financial health evaluation is rather negative. RAGE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RAGE had negative earnings in the past year.
In the past year RAGE has reported a negative cash flow from operations.
In the past 5 years RAGE always reported negative net income.
RAGE had a negative operating cash flow in each of the past 5 years.
RAGE.CA Yearly Net Income VS EBIT VS OCF VS FCFRAGE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -40.47%, RAGE is in line with its industry, outperforming 40.40% of the companies in the same industry.
RAGE has a Return On Equity (-48.25%) which is in line with its industry peers.
Industry RankSector Rank
ROA -40.47%
ROE -48.25%
ROIC N/A
ROA(3y)-58.99%
ROA(5y)-54.41%
ROE(3y)-72.82%
ROE(5y)-65.34%
ROIC(3y)N/A
ROIC(5y)N/A
RAGE.CA Yearly ROA, ROE, ROICRAGE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RAGE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RAGE.CA Yearly Profit, Operating, Gross MarginsRAGE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

RAGE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RAGE has more shares outstanding
The debt/assets ratio for RAGE has been reduced compared to a year ago.
RAGE.CA Yearly Shares OutstandingRAGE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
RAGE.CA Yearly Total Debt VS Total AssetsRAGE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

RAGE has an Altman-Z score of -5.36. This is a bad value and indicates that RAGE is not financially healthy and even has some risk of bankruptcy.
RAGE's Altman-Z score of -5.36 is on the low side compared to the rest of the industry. RAGE is outperformed by 67.78% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that RAGE is not too dependend on debt financing.
The Debt to Equity ratio of RAGE (0.02) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -5.36
ROIC/WACCN/A
WACCN/A
RAGE.CA Yearly LT Debt VS Equity VS FCFRAGE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 0.25 indicates that RAGE may have some problems paying its short term obligations.
RAGE has a Current ratio of 0.25. This is in the lower half of the industry: RAGE underperforms 75.96% of its industry peers.
RAGE has a Quick Ratio of 0.25. This is a bad value and indicates that RAGE is not financially healthy enough and could expect problems in meeting its short term obligations.
RAGE has a worse Quick ratio (0.25) than 75.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
RAGE.CA Yearly Current Assets VS Current LiabilitesRAGE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.07% over the past year.
EPS 1Y (TTM)79.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RAGE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RAGE.CA Price Earnings VS Forward Price EarningsRAGE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RAGE.CA Per share dataRAGE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RAGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RENEGADE GOLD INC

TSX-V:RAGE (9/16/2025, 7:00:00 PM)

0.11

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-28 2024-02-28
Earnings (Next)N/A N/A
Inst Owners1.25%
Inst Owner ChangeN/A
Ins Owners18.86%
Ins Owner ChangeN/A
Market Cap5.79M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 0.43
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.47%
ROE -48.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.99%
ROA(5y)-54.41%
ROE(3y)-72.82%
ROE(5y)-65.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 464.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -5.36
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)968.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.03%
OCF growth 3YN/A
OCF growth 5YN/A